On Tuesday, Aegean Marine Petroleum Network Inc. (NYSE:ANW)’s shares declined -17.96% to $9.23.
Aegean Marine Petroleum Network Inc. (ANW) declared financial and operating results for the second quarter ended June 30, 2015.
Second Quarter Highlights
- Recorded sales volumes of 3,150,950 metric tons.
- Recorded gross profit of $78.5 million.
- Recorded operating income of $14.8 million.
- Recorded net income attributable to Aegean shareholders of $7.1 million or $0.15 basic and diluted earnings per share.
- Recorded EBITDA of $24.1 million.
Aegean Marine Petroleum Network Inc., together with its auxiliaries, operates as a marine fuel logistics company that markets and supplies refined marine fuel and lubricants to vessels in port, at sea, and on rivers worldwide. The company offers fueling services to ocean going and a range of coastal vessels, counting oil tankers, container ships, drybulk carriers, cruise ships, reefers, LNG/LPG carriers, car carriers, and ferries, in addition to marine fuel traders, brokers, and other end-users of marine fuel and lubricants.
Knight Transportation (NYSE:KNX)’s shares gained 0.32% to $28.00.
Knight Transportation, Inc. (KNX) declared recently that its Board of Directors has declared the company’s quarterly cash dividend of $0.06 per share of common stock. This quarterly dividend is following a cash dividend policy approved by the Board of Directors. The actual declaration of future cash dividends, and the establishment of record and payment dates, is subject to final determination by the Board of Directors each quarter after its review of the company’s financial performance.
The company’s dividend is payable to shareholders of record on September 4, 2015 and is predictable to be paid on September 25, 2015.
Knight Transportation, Inc., together with its auxiliaries, operates as a short-to-medium haul truckload carrier of general commodities primarily in the United States. It operates through two segments, Trucking and Logistics. The Trucking segment offers truckload carrier dry van, temperature-controlled (refrigerated), and drayage services between ocean ports, rail ramps, and shipping docks.
At the end of Tuesday’s trade, Tronox Ltd (NYSE:TROX)‘s shares dipped -7.70% to $8.15.
Tronox Limited (TROX) stated second quarter 2015 revenue of $617 million contrast to $490 million in the second quarter 2014 and $385 million in the first quarter 2015. Adjusted EBITDA was $116 million, not taking into account $49 million of net lower of cost or market (LCM) charges, contrast to $103 million, not taking into account net non-cash LCM credits of $5 million, in the year-ago quarter and $73 million, not taking into account net non-cash LCM charges of $9 million, in the preceding quarter. Adjusted net loss attributable to Tronox Limited in the second quarter was $81 million, or $0.70 per diluted share, as compared to breakeven net income, or $0.00 per diluted share, in the year-ago quarter and a loss of $51 million, or $0.44 per diluted share, in the first quarter 2015.
Titanium Dioxide (TiO2)
TiO2 segment revenue of $409 million was 17 percent lower than $490 million in the preceding-year quarter, primarily the result of lower pigment products sales. Sales of pigment products declined 19 percent, as sales volumes declined 4 percent and average selling prices declined 16 percent (11 percent on a local currency basis). Sales volumes for pigment products rebounded in EMEA, declined in Asia-Pacific and softened modestly in North America as compared to the year-ago quarter. Sales of titanium feedstocks and co-products, counting zircon and rutile, declined 15 percent as compared to the year-ago quarter. Selling prices raised in the 4-6 percent range for titanium feedstocks. Sales volumes raised for CP titanium slag and rutile products declined. Zircon sales volumes remained at normal levels but were lower contrast to very strong sales volumes in the year-ago quarter and selling prices declined modestly.
Tronox Limited produces and markets titanium bearing mineral sands and titanium dioxide (TiO2) pigment in North America, Europe, South Africa, and the Asia-Pacific region. It primarily operates in two segments, Mineral Sands and Pigment.
Tenet Healthcare Corp (NYSE:THC), ended its Tuesday’s trading session with -1.15% loss, and closed at $51.80.
Tenet Healthcare Corporation (THC) stated Adjusted EBITDA of $568 million for the second quarter of 2015, an enhance of $108 million, or 23.5 percent, contrast to $460 million in the second quarter of 2014. The results for the second quarter of 2015 comprised of $16 million of Adjusted EBITDA generated by United Surgical Partners International (USPI) and Aspen Healthcare, which were attained by Tenet on June 16, 2015.
Tenet generated same-hospital growth in admissions and adjusted admissions of 1.7 percent and 2.3 percent, respectively, contrast to the second quarter of 2014. Paying admissions raised 2.1 percent, reflecting growth in the number of newly insured patients. Surgeries performed in our hospital segment raised 1.5 percent and emergency department visits raised 2.4 percent. On a pro forma same-facility system-wide basis, counting the results of USPI and Aspen in both the second quarters of 2015 and 2014, surgical and imaging cases in our Ambulatory Care segment grew by 6.8 percent.
The company continues to benefit from declines in uninsured and charity volumes. In the six states in which we operate that expanded their Medicaid programs, same-hospital uninsured plus charity admissions declined by 639 admissions, or 31.5 percent, and Medicaid admissions raised by 767 admissions, or 2.6 percent. Uninsured plus charity outpatient visits reduced by 8,729 visits, or 15.8 percent, and Medicaid outpatient visits grew by 32,714 visits, or 9.2 percent. The six states are comprised of five states that expanded Medicaid in 2014 (Arizona, California, Illinois, Massachusetts and Michigan) and one state that expanded Medicaid in 2015 (Pennsylvania).
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer. The company’s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
